Neuromotor Repertoires in Infants Exposed to Maternal COVID-19 During Pregnancy: a Cohort Study
Overview
Authors
Affiliations
Objective: To evaluate neuromotor repertoires and developmental milestones in infants exposed to antenatal COVID-19.
Design: Longitudinal cohort study.
Setting: Hospital-based study in Los Angeles, USA and Rio de Janeiro, Brazil between March 2020 and December 2021.
Participants: Infants born to mothers with COVID-19 during pregnancy and prepandemic control infants from the Graz University Database.
Interventions: General movement assessment (GMA) videos between 3 and 5 months post-term age were collected and clinical assessments/developmental milestones evaluated at 6-8 months of age. Cases were matched by gestational age, gender and post-term age to prepandemic neurotypical unexposed controls from the database.
Main Outcome Measures: Motor Optimality Scores Revised (MOS-R) at 3-5 months. Presence of developmental delay (DD) at 6-8 months.
Results: 239 infants were enrolled; 124 cases (83 in the USA/41 in Brazil) and 115 controls. GMA was assessed in 115 cases and 115 controls; 25% were preterm. Median MOS-R in cases was 23 (IQR 21-24, range 9-28) vs 25 (IQR 24-26, range 20-28) in controls, p<0.001. Sixteen infants (14%) had MOS-R scores <20 vs zero controls, p<0.001. At 6-8 months, 13 of 109 case infants (12%) failed to attain developmental milestones; all 115 control infants had normal development. The timing of maternal infection in pregnancy (first, second or third trimester) or COVID-19 disease severity (NIH categories asymptomatic, mild/moderate or severe/critical) was not associated with suboptimal MOS-R or DD. Maternal fever in pregnancy was associated with DD (OR 3.7; 95% CI 1.12 to 12.60) but not suboptimal MOS-R (OR 0.25; 95% CI 0.04 to 0.96).
Conclusions: Compared with prepandemic controls, infants exposed to antenatal COVID-19 more frequently had suboptimal neuromotor development.
The Effect of COVID-19 on Neonatal Outcomes in a Community Hospital.
Martinez-Baladejo M, Kerego Y, Walker A, Ohnona A, Scartelli C, Stoltzfus C J Clin Med. 2025; 14(2.
PMID: 39860424 PMC: 11766128. DOI: 10.3390/jcm14020420.
Deep learning empowered sensor fusion boosts infant movement classification.
Kulvicius T, Zhang D, Poustka L, Bolte S, Jahn L, Flugge S Commun Med (Lond). 2025; 5(1):16.
PMID: 39809877 PMC: 11733215. DOI: 10.1038/s43856-024-00701-w.
Physical development of infants born to patients with COVID-19 during pregnancy: 2 years of age.
Eligulashvili A, Gordon M, Nemerofsky S, Havranek T, Bernstein P, Yee J PeerJ. 2024; 12:e18481.
PMID: 39553723 PMC: 11566510. DOI: 10.7717/peerj.18481.
Arguelho A, Nazario A, Ribeiro A, Cunha A, Soares-Marangoni D Mhealth. 2024; 10:32.
PMID: 39534456 PMC: 11557160. DOI: 10.21037/mhealth-24-20.
Maternal COVID-19 infection associated with offspring neurodevelopmental disorders.
Duan L, Yin H, Liu J, Wang W, Huang P, Liu L Mol Psychiatry. 2024; .
PMID: 39521839 DOI: 10.1038/s41380-024-02822-z.